Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Trans-Ferulic acid, also known as 4-hydroxy-3-methoxycinnamic acid, is a naturally occurring organic compound found in various plants and is known for its antioxidant and anti-inflammatory properties. It is a solid substance with a molecular formula of C10H10O4 and is characterized by its ability to scavenge free radicals and inhibit the formation of reactive oxygen species.

537-98-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 537-98-4 Structure
  • Basic information

    1. Product Name: trans-Ferulic acid
    2. Synonyms: (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoic acid;(e)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoicacid;(e)-ferulicacid;3-(4-Hydroxy-3-methoxyphenyl)propenoic acid;Cinnamic acid, 4-hydroxy-3-methoxy-, (E)-;Cinnamic acid, 4-hydroxy-3-methoxy-, trans-;Ferulic acid, trans-;trans-cinnamicaci
    3. CAS NO:537-98-4
    4. Molecular Formula: C10H10O4
    5. Molecular Weight: 194.18
    6. EINECS: 208-679-7
    7. Product Categories: Cinnamic acid;Antioxidant;Biochemistry
    8. Mol File: 537-98-4.mol
  • Chemical Properties

    1. Melting Point: 168-172 °C(lit.)
    2. Boiling Point: 250.62°C (rough estimate)
    3. Flash Point: 150℃
    4. Appearance: slightly yellow/powder
    5. Density: 1.316(20.0000℃)
    6. Vapor Pressure: 0Pa at 25℃
    7. Refractive Index: 1.5030 (estimate)
    8. Storage Temp.: Store below +30°C.
    9. Solubility: DMSO (Slightly), Methanol (Slightly)
    10. PKA: 4.58±0.10(Predicted)
    11. Water Solubility: Soluble in alcohol and hot water.
    12. Stability: Stable. Incompatible with strong oxidizing agents.
    13. Merck: 14,4062
    14. BRN: 1371483
    15. CAS DataBase Reference: trans-Ferulic acid(CAS DataBase Reference)
    16. NIST Chemistry Reference: trans-Ferulic acid(537-98-4)
    17. EPA Substance Registry System: trans-Ferulic acid(537-98-4)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36
    4. WGK Germany: 3
    5. RTECS: UD3365500
    6. TSCA: Yes
    7. HazardClass: IRRITANT
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 537-98-4(Hazardous Substances Data)

537-98-4 Usage

Uses

Used in Pharmaceutical Applications:
Trans-Ferulic acid is used as an active pharmaceutical ingredient for its antioxidant and anti-inflammatory properties. It is particularly effective in the treatment of various inflammatory conditions and has been shown to have neuroprotective effects.
Used in Food and Beverage Industry:
Trans-Ferulic acid is used as a natural antioxidant in the food and beverage industry to extend the shelf life of products and maintain their quality. It is also used as a flavor enhancer and color stabilizer due to its ability to prevent oxidation and rancidity.
Used in Cosmetics:
Trans-Ferulic acid is used as an ingredient in the cosmetics industry for its antioxidant and anti-aging properties. It is commonly found in skincare products, where it helps to protect the skin from environmental damage and promotes a youthful appearance.
Used in Analytical Applications:
Trans-Ferulic acid is used as a secondary standard in several analytical applications, including pharmaceutical release testing, method development for qualitative and quantitative analyses, and food and beverage quality control testing. It is also used for calibration requirements in various industries.
Used in Synthesis of Biocompatible Antioxidant Polymers:
Trans-Ferulic acid is used in the synthesis of new biocompatible antioxidant polymers, which have potential applications in the medical field. These polymers can be used for drug delivery systems, tissue engineering, and other biomedical applications.
Used in Esterification of Methacrylated Dextran:
Trans-Ferulic acid is used for the esterification of methacrylated dextran, a process that can improve the properties of the resulting polymer and enhance its potential applications in various industries.
Used in Ethanol-Induced Liver Injury Studies:
Trans-Ferulic acid has been used to study the effects of oral administration on ethanol-induced liver injury in C57BL mice. This research can provide valuable insights into the potential therapeutic applications of trans-ferulic acid in the treatment of liver diseases.

Biochem/physiol Actions

Hydroxycinnamic acid found in plant-based foods. Antioxidant.

Check Digit Verification of cas no

The CAS Registry Mumber 537-98-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,3 and 7 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 537-98:
(5*5)+(4*3)+(3*7)+(2*9)+(1*8)=84
84 % 10 = 4
So 537-98-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H10O4/c1-14-9-6-7(2-4-8(9)11)3-5-10(12)13/h2-6,11H,1H3,(H,12,13)/b5-3+

537-98-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H0267)  trans-Ferulic Acid  >98.0%(GC)(T)

  • 537-98-4

  • 25g

  • 570.00CNY

  • Detail
  • TCI America

  • (H0267)  trans-Ferulic Acid  >98.0%(GC)(T)

  • 537-98-4

  • 250g

  • 2,990.00CNY

  • Detail
  • Alfa Aesar

  • (A13890)  trans-4-Hydroxy-3-methoxycinnamic acid, 99%   

  • 537-98-4

  • 25g

  • 372.0CNY

  • Detail
  • Alfa Aesar

  • (A13890)  trans-4-Hydroxy-3-methoxycinnamic acid, 99%   

  • 537-98-4

  • 100g

  • 1163.0CNY

  • Detail
  • Alfa Aesar

  • (A13890)  trans-4-Hydroxy-3-methoxycinnamic acid, 99%   

  • 537-98-4

  • 500g

  • 4731.0CNY

  • Detail
  • Sigma-Aldrich

  • (52229)  trans-Ferulic acid  certified reference material, TraceCERT®

  • 537-98-4

  • 52229-50MG

  • 1,075.23CNY

  • Detail
  • Sigma-Aldrich

  • (Y0001013)  Ferulic acid  European Pharmacopoeia (EP) Reference Standard

  • 537-98-4

  • Y0001013

  • 1,880.19CNY

  • Detail

537-98-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Trans-Ferulic Acid

1.2 Other means of identification

Product number -
Other names trans-Ferulic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Food additives -> Flavoring Agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:537-98-4 SDS

537-98-4Relevant articles and documents

Photoinduced Regioselective Olefination of Arenes at Proximal and Distal Sites

Ali, Wajid,Anjana, S. S.,Bhattacharya, Trisha,Chandrashekar, Hediyala B.,Goswami, Nupur,Guin, Srimanta,Maiti, Debabrata,Panda, Sanjib,Prakash, Gaurav,Saha, Argha,Sasmal, Sheuli,Sinha, Soumya Kumar

, p. 1929 - 1940 (2022/02/01)

The Fujiwara-Moritani reaction has had a profound contribution in the emergence of contemporary C-H activation protocols. Despite the applicability of the traditional approach in different fields, the associated reactivity and regioselectivity issues had

Synthesis, spectrophotometric, spectroscopic, microbial studies and analytical applications of Cu(II) and Zn(II) complexes of chalcone ligand

Abd El-wahaab, Badr,El-Shwiniy, Walaa H.,Shehab, Wesam S.

, (2021/10/14)

The ligation behavior of the chalcone ligand namely (E)-3-(4-hydroxy-3-methoxyphenyl) acrylic acid (ferulic acid) (FA) toward the Cu(II) and Zn(II) ions was determined. The structure of the isolated solid complexes was elucidated by elemental analyses, spectral techniques (IR, UV–Vis, 13C– and 1H-NMR spectra) as well as the conductance measurements and thermal analyses. UV–Vis spectra and magnetic moments had suggested square planar and tetrahedral stereochemistry for Cu(II) and Zn(II) complexes, respectively. The kinetic and thermodynamic parameters for some selected decomposition steps have been calculated. Two precise and sensitive spectrophotometric methods were utilized to determine Zn(II) and Cu(II) complexes with ferulic acid using a micellar media of cetylpyridinium bromide (CPB) and sodium lauryl sulfate (SLS) with an absorption maxima of 430 and 465?nm for Zn(II) and Cu(II), respectively. Various analytical conditions, for example, the concentration of the reagent, temperature, the sequence and timing of addition were also looked into. Under optimum conditions, the complexes exhibited good linearity in concentration range of 2.0–70.0 and 4.0–140.0?μg?mL?1; molar absorptivities 1.3161 × 104 and 8.826 × 103 L mol?1?cm?1; and Sandell’s sensitivity 0.00496 and 0.00719?μg?cm?2 for the proposed methods of Zn(II) and Cu(II), respectively. The complexes ratio was found to be 1:2 [Zn(II):FA or Cu(II):FA] and the stability constants were 2.771 × 105 and 2.826 × 105, respectively. Finally, the newly synthesized complexes were shown potent antimicrobial activity.

First total syntheses of four natural bioactive glucosides

Xu, Guangya,Wu, Min,Yao, Zhongquan,Lou, Hongbin,Du, Weihong,Song, Mingwei,He, Yujiao,Dong, Hongbo

supporting information, p. 1266 - 1271 (2021/02/06)

The efficient total syntheses of four biologically interesting natural glucosides Ethylconiferin, Butylconiferin, 2’-Butoxyethylconiferin and Balajaponin B, have been achieved for the first time starting from commercially available Vanilline via concise reaction sequence of 8–10 steps with the overall yield of 26–41%. This work definitely laid the foundation for the further pharmacological study of this kind of natural compounds. Meanwhile, currently developed approach could be used as a general synthetic strategy for the syntheses of other monolignol glucosides and their derivatives, and provides an opportunity for further study of the structure-activity relationship of this kind of glucosides.

Discovery of 3-cinnamamido-n-substituted benzamides as potential antimalarial agents

Futamura, Yushi,Ishiyama, Aki,Iwatsuki, Masato,Liu, Haicheng,Osada, Hiroyuki,Shi, Tao,Wu, Honghai,Zhang, Taotao,Zheng, Qunxiong,Zou, Hongbin,ōmura, Satoshi

, p. 1207 - 1218 (2022/01/06)

Background: Malaria is one of the most devastating parasitic diseases, yet the discovery of antimalarial agents remains profoundly challenging. Very few new antimalarials have been developed in the past 50 years, while the emergence of drug-resistance continues to appear. Objective: This study focuses on the discovery, design, synthesis, and antimalarial evaluation of 3- cinnamamido-N-substituted benzamides. Methods: In this study, a screening of our compound library was carried out against the multidrugsensitive Plasmodium falciparum 3D7 strain. Derivatives of the hit were designed, synthesized and tested against P. falciparum 3D7 and the in vivo antimalarial activity of the most active compounds was evaluated using the method of Peters’ 4-day suppressive test. Results: The retrieved hit compound 1 containing a 3-cinnamamido-N-substituted benzamide skeleton showed moderate antimalarial activity (IC50 = 1.20 μM) for the first time. A series of derivatives were then synthesized through a simple four-step workflow, and half of them exhibited slightly better antimalarial effect than the precursor 1 during the subsequent in vitro assays. Additionally, compounds 11, 23, 30 and 31 displayed potent activity with IC50 values of approximately 0.1 μM, and weak cytotoxicity against mammalian cells. However, in vivo antimalarial activity is not effective, which might be ascribed to the poor solubility of these compounds. Conclusion: In this study, the phenotypic screen of our compound library resulted in the first report of a 3-cinnamamide framework with antimalarial activity and 40 derivatives were then designed and synthesized. Subsequent structure-activity studies showed that compounds 11, 23, 30 and 31 exhibited the most potent and selective activity against the P. falciparum 3D7 strain with IC50 values around 0.1 μM. Our work herein sets another example of phenotypic screen-based drug discovery, leading to potentially promising candidates of novel antimalarial agents once given further optimization.

A chlorogenic acid esterase from a metagenomic library with unique substrate specificity and its application in caffeic and ferulic acid production from agricultural byproducts

Gui, Lun,Long, Qizhang,Yao, Jian

, (2021/08/25)

Soil microbes are an abundant source of enzymes with unique properties that may be useful for industrial applications. As most wild-type strains show low chlorogenic acid esterase expression and activity, and most microbes cannot be cultured in the laboratory, a metagenomic approach provides methods of identifying new enzymes. In this study, a gene encoding a chlorogenic acid esterase, named Tan410, was isolated from a soil metagenomic library and overexpressed in Escherichia coli BL21 (DE3). The recombinant enzyme, with a predicted molecular weight of 54.88 kDa, was purified to homogeneity. The K m and V max values for Tan410 were 1.26 mM and 0.33 mM min–1, respectively, with chlorogenic acid as the substrate. Its optimum temperature and pH for reaction were 30 °C and 7.5, respectively. The enzyme exhibited moderate thermostability and broad pH stability (3.0–10.0). Tan410 was also able to hydrolyse ethyl ferulate, methyl caffeate, propyl gallate, ethyl gallate, methyl vanillate, methyl benzoate, ethyl benzoate, methyl 2,5-dihydroxybenzoate, and methyl 3,5-dihydroxybenzoate, and it released caffeic and ferulic acids from agricultural byproducts (destarched wheat bran and coffee pulp). Tan140 has potential for industrial application in biomass valorization.

A Series of Ferulic Acid Amides Reveals Unexpected Peroxiredoxin 1 Inhibitory Activity with in vivo Antidiabetic and Hypolipidemic Effects

Yasmin, Sabina,Cerchia, Carmen,Badavath, Vishnu Nayak,Laghezza, Antonio,Dal Piaz, Fabrizio,Mondal, Susanta K.,Atl?, ?zlem,Baysal, Merve,Vadivelan, Sankaran,Shankar,Siddique, Mohd Usman Mohd,Pattnaik, Ashok Kumar,Singh, Ravi Pratap,Loiodice, Fulvio,Jayaprakash, Venkatesan,Lavecchia, Antonio

, p. 484 - 498 (2020/11/02)

Insulin resistance is a major pathophysiological feature in the development of type 2 diabetes (T2DM). Ferulic acid is known for attenuating the insulin resistance and reducing the blood glucose in T2DM rats. In this work, we designed and synthesized a library of new ferulic acid amides (FAA), which could be considered as ring opening derivatives of the antidiabetic PPARγ agonists Thiazolidinediones (TZDs). However, since these compounds displayed weak PPAR transactivation capacity, we employed a proteomics approach to unravel their molecular target(s) and identified the peroxiredoxin 1 (PRDX1) as a direct binding target of FAAs. Interestingly, PRDX1, a protein with antioxidant and chaperone activity, has been implied in the development of T2DM by inducing hepatic insulin resistance. SPR, mass spectrometry-based studies, docking experiments and in vitro inhibition assay confirmed that compounds VIe and VIf bound PRDX1 and induced a dose-dependent inhibition. Furthermore, VIe and VIf significantly improved hyperglycemia and hyperlipidemia in streptozotocin-nicotinamide (STZ-NA)-induced diabetic rats as confirmed by histopathological examinations. These results provide guidance for developing the current FAAs as new potential antidiabetic agents.

Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate

Zhou, Yu,Fu, Yan,Yin, Wanchao,Li, Jian,Wang, Wei,Bai, Fang,Xu, Shengtao,Gong, Qi,Peng, Tao,Hong, Yu,Zhang, Dong,Zhang, Dan,Liu, Qiufeng,Xu, Yechun,Xu, H. Eric,Zhang, Haiyan,Jiang, Hualiang,Liu, Hong

, p. 1844 - 1855 (2021/03/01)

The acetylcholinesterase (AChE) inhibitors remain key therapeutic drugs for the treatment of Alzheimer's disease (AD). However, the low-safety window limits their maximum therapeutic benefits. Here, a novel kinetics-driven drug design strategy was employed to discover new-generation AChE inhibitors that possess a longer drug-target residence time and exhibit a larger safety window. After detailed investigations, compound 12 was identified as a highly potent, highly selective, orally bioavailable, and brain preferentially distributed AChE inhibitor. Moreover, it significantly ameliorated cognitive impairments in different mouse models with a lower effective dose than donepezil. The X-ray structure of the cocrystal complex provided a precise binding mode between 12 and AChE. Besides, the data from the phase I trials demonstrated that 12 had good safety, tolerance, and pharmacokinetic profiles at all preset doses in healthy volunteers, providing a solid basis for its further investigation in phase II trials for the treatment of AD.

A Thorough Study on the Photoisomerization of Ferulic Acid Derivatives

Moni, Lisa,Banfi, Luca,Basso, Andrea,Mori, Alessia,Risso, Federica,Riva, Renata,Lambruschini, Chiara

supporting information, p. 1737 - 1749 (2021/03/23)

A thorough study on the (E) to (Z) photoisomerization of ferulic acid derivatives (esters, amides of all types, and ketones) was carried out. At the photostationary state, only aliphatic or benzylic tertiary amides reach a nearly complete conversion of (E) isomers into the (Z) ones, whereas for esters, primary and secondary amides or aromatic tertiary amides mixtures of (Z)/(E) ranging from 7 : 93 to 72 : 28 are observed. Ketones show rather limited photoisomerization. However, (Z) ketones may be obtained by the reaction of organometal compounds with an isomerized (Z) Weinreb amide.

S-Adenosylhomocysteine Analogue of a Fairy Chemical, Imidazole-4-carboxamide, as its Metabolite in Rice and Yeast and Synthetic Investigations of Related Compounds

Ouchi, Hitoshi,Namiki, Takuya,Iwamoto, Kenji,Matsuzaki, Nobuo,Inai, Makoto,Kotajima, Mihaya,Wu, Jing,Choi, Jae-Hoon,Kimura, Yoko,Hirai, Hirofumi,Xie, Xiaonan,Kawagishi, Hirokazu,Kan, Toshiyuki

, p. 453 - 458 (2021/02/05)

During the course of our investigations of fairy chemicals (FCs), we found S-ICAr-H (8a), as a metabolite of imidazole-4-carboxamide (ICA) in rice and yeast (Saccharomyces cerevisiae). In order to determine its absolute configuration, an efficient synthetic method of 8a was developed. This synthetic strategy was applicable to the preparation of analogues of 8a that might be biologically very important, such as S-ICAr-M (9), S-AICAr-H (10), and S-AICAr-M (11).

Novel method for preparing ferulic acid

-

Paragraph 0018; 0041-0056, (2021/07/09)

The invention provides a novel method for preparing ferulic acid, and belongs to the field of medicine synthesis. According to the method, vanillin and Meldrum's acid are taken as initial raw materials, organic acid is taken as a catalyst, and ferulic acid is obtained through reaction. According to the preparation process, cheap and easily available starting raw materials are adopted, the synthesis process is green and environment-friendly, and waste liquid and organic solvents generated in a reaction system and post-treatment are less; the operation process is simple and convenient, the feeding procedure is simple, special equipment does not need to be added, all steps are conventional steps; the control of related parameters can also be in a certain range, and the final yield and purity of the product cannot be influenced by small parameter changes; and the process is stable and suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 537-98-4